Accessibility Statement Skip Navigation
  • Why PRWeb
  • How It Works
  • Who Uses It
  • Pricing
  • Login
  • GDPR
  • Create a Free Account
Return to PRWeb homepage
  • News
  • Resources
  • Contact
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News in Focus
      • Browse News Releases

      • All News Releases
      • Multimedia Gallery

      • All Multimedia
      • All Photos
      • All Videos
  • Business & Money
      • Auto & Transportation

      • Aerospace, Defense
      • Air Freight
      • Airlines & Aviation
      • Automotive
      • Maritime & Shipbuilding
      • Railroads and Intermodal Transportation
      • Supply Chain/Logistics
      • Transportation, Trucking & Railroad
      • Travel
      • Trucking and Road Transportation
      • View All Auto & Transportation

      • Business Technology

      • Blockchain
      • Broadcast Tech
      • Computer & Electronics
      • Computer Hardware
      • Computer Software
      • Data Analytics
      • Electronic Commerce
      • Electronic Components
      • Electronic Design Automation
      • Financial Technology
      • High Tech Security
      • Internet Technology
      • Nanotechnology
      • Networks
      • Peripherals
      • Semiconductors
      • View All Business Technology

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Financial Services & Investing

      • Accounting News & Issues
      • Acquisitions, Mergers and Takeovers
      • Banking & Financial Services
      • Bankruptcy
      • Bond & Stock Ratings
      • Conference Call Announcements
      • Contracts
      • Cryptocurrency
      • Dividends
      • Earnings
      • Earnings Forecasts & Projections
      • Financing Agreements
      • Insurance
      • Investments Opinions
      • Joint Ventures
      • Mutual Funds
      • Private Placement
      • Real Estate
      • Restructuring & Recapitalization
      • Sales Reports
      • Shareholder Activism
      • Shareholder Meetings
      • Stock Offering
      • Stock Split
      • Venture Capital
      • View All Financial Services & Investing

      • General Business

      • Awards
      • Commercial Real Estate
      • Corporate Expansion
      • Earnings
      • Environmental, Social and Governance (ESG)
      • Human Resource & Workforce Management
      • Licensing
      • New Products & Services
      • Obituaries
      • Outsourcing Businesses
      • Overseas Real Estate (non-US)
      • Personnel Announcements
      • Real Estate Transactions
      • Residential Real Estate
      • Small Business Services
      • Socially Responsible Investing
      • Surveys, Polls and Research
      • Trade Show News
      • View All General Business

  • Science & Tech
      • Consumer Technology

      • Artificial Intelligence
      • Blockchain
      • Cloud Computing/Internet of Things
      • Computer Electronics
      • Computer Hardware
      • Computer Software
      • Consumer Electronics
      • Cryptocurrency
      • Data Analytics
      • Electronic Commerce
      • Electronic Gaming
      • Financial Technology
      • Mobile Entertainment
      • Multimedia & Internet
      • Peripherals
      • Social Media
      • STEM (Science, Tech, Engineering, Math)
      • Supply Chain/Logistics
      • Wireless Communications
      • View All Consumer Technology

      • Energy & Natural Resources

      • Alternative Energies
      • Chemical
      • Electrical Utilities
      • Gas
      • General Manufacturing
      • Mining
      • Mining & Metals
      • Oil & Energy
      • Oil and Gas Discoveries
      • Utilities
      • Water Utilities
      • View All Energy & Natural Resources

      • Environ­ment

      • Conservation & Recycling
      • Environmental Issues
      • Environmental Policy
      • Environmental Products & Services
      • Green Technology
      • Natural Disasters
      • View All Environ­ment

      • Heavy Industry & Manufacturing

      • Aerospace & Defense
      • Agriculture
      • Chemical
      • Construction & Building
      • General Manufacturing
      • HVAC (Heating, Ventilation and Air-Conditioning)
      • Machinery
      • Machine Tools, Metalworking and Metallurgy
      • Mining
      • Mining & Metals
      • Paper, Forest Products & Containers
      • Precious Metals
      • Textiles
      • Tobacco
      • View All Heavy Industry & Manufacturing

      • Telecomm­unications

      • Carriers and Services
      • Mobile Entertainment
      • Networks
      • Peripherals
      • Telecommunications Equipment
      • Telecommunications Industry
      • VoIP (Voice over Internet Protocol)
      • Wireless Communications
      • View All Telecomm­unications

  • Lifestyle & Health
      • Consumer Products & Retail

      • Animals & Pets
      • Beers, Wines and Spirits
      • Beverages
      • Bridal Services
      • Cannabis
      • Cosmetics and Personal Care
      • Fashion
      • Food & Beverages
      • Furniture and Furnishings
      • Home Improvement
      • Household, Consumer & Cosmetics
      • Household Products
      • Jewelry
      • Non-Alcoholic Beverages
      • Office Products
      • Organic Food
      • Product Recalls
      • Restaurants
      • Retail
      • Supermarkets
      • Toys
      • View All Consumer Products & Retail

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Health

      • Biometrics
      • Biotechnology
      • Clinical Trials & Medical Discoveries
      • Dentistry
      • FDA Approval
      • Fitness/Wellness
      • Health Care & Hospitals
      • Health Insurance
      • Infection Control
      • International Medical Approval
      • Medical Equipment
      • Medical Pharmaceuticals
      • Mental Health
      • Pharmaceuticals
      • Supplementary Medicine
      • View All Health

      • Sports

      • General Sports
      • Outdoors, Camping & Hiking
      • Sporting Events
      • Sports Equipment & Accessories
      • View All Sports

      • Travel

      • Amusement Parks and Tourist Attractions
      • Gambling & Casinos
      • Hotels and Resorts
      • Leisure & Tourism
      • Outdoors, Camping & Hiking
      • Passenger Aviation
      • Travel Industry
      • View All Travel

  • Policy & Public Interest
      • Policy & Public Interest

      • Advocacy Group Opinion
      • Animal Welfare
      • Congressional & Presidential Campaigns
      • Corporate Social Responsibility
      • Domestic Policy
      • Economic News, Trends, Analysis
      • Education
      • Environmental
      • European Government
      • FDA Approval
      • Federal and State Legislation
      • Federal Executive Branch & Agency
      • Foreign Policy & International Affairs
      • Homeland Security
      • Labor & Union
      • Legal Issues
      • Natural Disasters
      • Not For Profit
      • Patent Law
      • Public Safety
      • Trade Policy
      • U.S. State Policy
      • View All Policy & Public Interest

  • People & Culture
      • People & Culture

      • Aboriginal, First Nations & Native American
      • African American
      • Asian American
      • Children
      • Diversity, Equity & Inclusion
      • Hispanic
      • Lesbian, Gay & Bisexual
      • Men's Interest
      • People with Disabilities
      • Religion
      • Senior Citizens
      • Veterans
      • Women
      • View All People & Culture

  • Hamburger menu
  • Cision PRWeb provides efficient communication tools to continuously engage with target audiences across multiple online channels
  • Create a Free Account
    • ALL CONTACT INFO
    • Contact Us


      11AM ET Sunday – 8PM ET Friday

  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • News in Focus
    • Browse All News
    • Multimedia Gallery
  • Business & Money
    • Auto & Transportation
    • Business Technology
    • Entertain­ment & Media
    • Financial Services & Investing
    • General Business
  • Science & Tech
    • Consumer Technology
    • Energy & Natural Resources
    • Environ­ment
    • Heavy Industry & Manufacturing
    • Telecomm­unications
  • Lifestyle & Health
    • Consumer Products & Retail
    • Entertain­ment & Media
    • Health
    • Sports
    • Travel
  • Policy & Public Interest
  • People & Culture
    • People & Culture
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR

Spaulding Rehabilitation Announces Open Registration for Their Milestone Event, Regen Rehab '24, The 10th Annual International Symposium on Regenerative Rehabilitation


News provided by

Alliance for Regenerative Rehabilitation Research & Training

Dec 16, 2023, 12:08 ET

Share this article

Share toX

Share this article

Share toX


Explore the potential impacts of regenerative rehabilitation alongside keynote speakers Ana Rodriguez Castillo and Alan J. Grodzinsky, ScD as well as course directors Fabrisia Ambrosio, PhD, MPT and Joanne Borg-Stein, MD. This three-day atom-smashing event complete with expert analysis and discussion, collegial presentations, ample networking opportunities, and a pitch competition awarding $10,000 in funding for novel regenerative rehabilitation research will be held live at The Harvard Club in Boston, March 7-9, 2024.

BOSTON, Dec. 16, 2023 /PRNewswire-PRWeb/ -- Spaulding Rehabilitation Hospital is honored to announce the commencement of registration for Regen Rehab '24, The 10th Annual International Symposium on Regenerative Rehabilitation, a Harvard Medical School accredited milestone event, scheduled to take place live in Boston, March 7-9, 2024, at The Harvard Club. The 10th edition of the symposium promises to provide attendees with a comprehensive and insightful exploration of the intersection of regenerative medicine and rehabilitation, paving the way for a future of personalized regenerative treatments and innovative approaches to patient care.

Advances in regenerative medicine have already demonstrated transformative potential in clinical practice. With thousands of ongoing regenerative medicine clinical trials involving tens of thousands of patients, the availability of regenerative therapies is on the cusp of significant expansion, promising new hope for a diverse range of patients under the care of clinicians. Featured speakers from around the world recognize that this exciting progress is poised to usher in a new era in healthcare, enabling clinicians to offer innovative solutions for a broader patient base. "We are thrilled to be hosting the 10th edition of this atom-smashing event in Boston. Our program encompasses the latest advancements in regenerative therapy, fostering a collaborative environment for professionals across various therapeutic domains to engage and share insights. Additionally, I am exceptionally proud of our various initiatives designed to bring new perspectives and voices to the forefront of the regenerative therapy conversation, such as our diversity breakfast and poster session." - Course Director Fabrisia Ambrosio, PhD, MPT

"We are thrilled to host the 10th edition of this atom-smashing event in Boston. Our program highlights the latest advancements in regenerative therapy, fostering a collaborative environment for professionals across various therapeutic domains to engage and share insights."

Post this

Featured Keynote Speakers:

Ana Rodríguez Castillo is an artist, art historian, and art educator. In humanities and all scientific disciplines there is an awareness of the challenges around defining authorship, ownership of ideas, and recognizing the evolution and progress of innovation and discovery. In the popular, and Romantic notion, of genius – be it from a philosopher, author, artist, or scientist – the most important and amazing creations and discoveries materialize in solitude or isolation. But this model rarely, if ever, occurs in reality. All scientific discovery, artistic creation, and paradigm shifts in philosophy, art, and culture, are dependent on the interpretation and variation of what was done previously. What is critical is that the challenge of defining authorship and ownership of ideas is not limited to science. In fact, art and artists have struggled with similar challenges, which is what I will focus on in this presentation. Can an artist that works alone avoid having work read as an emulation, a copy, a version or an appropriation of another work? How original can an idea be? What determines ownership or authorship of an artwork? There is not a straightforward answer for these questions, but we should be carefully considering and reconsidering some of the rigid old-fashioned ideas and open a dialogue that acknowledges the complexities of creative work.

Alan Grodzinsky, ScD is the Director of MIT's Center for Biomedical Engineering and is Professor of Biological, Electrical and Mechanical Engineering in the MIT (Massachusetts Institute of Technology) Departments of Biological Engineering, Electrical Engineering and Computer Science and Mechanical Engineering. Traumatic joint injuries can initiate degeneration of cartilage and other joint tissues in the presence of elevated inflammation, leading to post-traumatic osteoarthritis (PTOA). Such injuries are increasingly common, especially among young women who suffer ACL and meniscus tears during sports activities. The effects of mechanical loading on cartilage degradation and the potential for tissue regeneration after injury are not well-understood, but very important to clinical rehabilitation. There are currently no disease modifying drugs for osteoarthritis, and a major challenge is the ability to achieve sustained levels of therapeutics inside a target tissue with no off-target side effects. We use in vitro organ culture models to study the beneficial effects of mechanical loading and therapeutics to inhibit tissue degradation and cell death. Parallel in vitro and animal studies are aimed at targeted tissue drug delivery. Our most recent studies involve human knee cartilage-bone-synovium cocultures on Earth and launched to the International Space Station on SpaceX-17/21, the latter to study effects of microgravity and radiation on initiation and progression of OA-like disease, and the benefits of potential therapeutics.

Accompanying the presentations from this year's keynote speakers, Regen Rehab '24 will feature various other interactive presentations focused on restoring and revitalizing neuromuscular health at the intersection of regenerative medicine and rehabilitation, stem cell therapies and rehabilitation, and rebuilding cartilage with tissue engineering.

Additionally, Spaulding Rehabilitation Hospital's 10th Annual International Symposium will host a pitch competition for a chance to win $10,000 that will support novel regenerative rehabilitation research directions, a clinical special interest group, and student and trainee engagement opportunities. Furthermore, to promote diversity and inclusion within the regenerative rehabilitation community, Regen Rehab '24 is awarding over $20,000 in travel and diversity grants to support graduate students, medical fellows, medical residents, predoctoral fellows, and junior investigators from all walks of life. The deadline to apply for travel and diversity grants awarded through Regen Rehab '24 is January 15, 2024.

Spaulding Rehabilitation Hospital's Regen Rehab '24 is a Harvard Medical School accredited continuing medical education course. In support of improving patient care, Harvard Medical School is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team. The Harvard Medical School designates this live activity for a maximum of 11.50 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity. The course is designed to meet the following American Board of Medical Specialties (ABMS) / Accreditation Council for Graduate Medical Educational (ACGME) competencies: Medical Knowledge. This course is designed to meet the following Institute of Medicine Core Competencies: Employee Evidence-Based Practice.

Registration is now open, and early bird discounts are available until January 15, 2024. Do not miss the opportunity to be a part of this milestone event. For more information about Regen Rehab '24 please visit the event website: https://ar3t.pitt.edu/symposium/, to register for Regen Rehab '24, the 10th Annual International Symposium on Regenerative Rehabilitation, please visit the registration page: https://cmecatalog.hms.harvard.edu/symposium-regenerative-rehabilitation.

About Alliance for Regenerative Rehabilitation Research & Training (AR3T): AR3T is an alliance of institutions whose participating researchers provide educational resources, expert consultations, and research opportunities to expand scientific knowledge, expertise, and methodologies across the domains of rehabilitation science and regenerative medicine. AR3T is part of the National Institutes of Health (NIH) Medical Rehabilitation Research Resource Network (MR3). Funding for the Alliance for Regenerative Rehabilitation Research and Training is supported by the Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) and the National Institute of Biomedical Imaging and Bioengineering (NIBIB) of the National Institutes of Health under award number P2CHD086843. For more information about AR3T visit: https://ar3t.pitt.edu/symposium/.

About Spaulding Rehabilitation Hospital: Spaulding Rehabilitation Hospital is a world leader in advanced rehabilitation treatment and research – serving the greater Boston region and beyond. With three inpatient hospitals, a skilled nursing facility and outpatient centers across eastern Massachusetts, our leading medical professionals, clinicians, and researchers will help you through your most challenging journey, so you can be the best version of yourself. For more information about Spaulding Rehabilitation Hospital, please visit https://spauldingrehab.org/

Media Contact

Andrew Nugent, Alliance for Regenerative Rehabilitation Research & Training, 1 617-226-1900, [email protected], http://www.ar3t.pitt.edu/

SOURCE Alliance for Regenerative Rehabilitation Research & Training

Modal title

The 10th Annual International Symposium on Regenerative Rehabilitation March 7-9, 2023 at The Harvard Club
The 10th Annual International Symposium on Regenerative Rehabilitation March 7-9, 2023 at The Harvard Club
Featured Keynote Speaker: Ana Rodríguez Castillo
Featured Keynote Speaker: Ana Rodríguez Castillo
Featured Keynote Speaker: Alan Grodzinsky, ScD
Featured Keynote Speaker: Alan Grodzinsky, ScD
The 10th Annual International Symposium on Regenerative Rehabilitation March 7-9, 2023 at The Harvard Club Featured Keynote Speaker: Ana Rodríguez Castillo Featured Keynote Speaker: Alan Grodzinsky, ScD

Contact PRWeb

  • 11AM ET Sunday – 8PM ET Friday
  • Contact Us

About PRWeb

  • About PRWeb
  • Partners
  • Partnership Programs
  • Editorial Guidelines
  • Resources

Why PRWeb

  • Why PRWeb
  • How It Works
  • Who Uses It
  • Pricing

Accounts

  • Create a Free Account
  • Log in
  • Contact Us

Do not sell or share my personal information:

  • Submit via [email protected] 
  • Call Privacy toll-free: 877-297-8921

Contact Cision

Products

About

My Services
  • All News Releases
  • Online Member Center
  • ProfNet
Cision Distribution Helpline
888-776-0942
  • Legal
  • Site Map
  • RSS
  • Cookie Settings
Copyright © 2025 Cision US Inc.